Pantoprazole EC 40 Mg & Domperidone (SR) 30 Mg Capsules IP – Zentro DSR Capsules

Zentro DSR Capsules
Composition:- Pantoprazole (EC) 40 mg + Domperidone (SR) 30 mg

Zentro DSR Capsules – Pantoprazole EC 40 Mg & Domperidone (SR) 30 Mg Capsules IP, a combination therapy of Pantoprazole (enteric-coated), a proton pump inhibitor (PPI), and Domperidone (sustained-release), a prokinetic agent. This formulation provides effective acid suppression along with improved gastric motility, making it suitable for gastroesophageal reflux disease (GERD), dyspepsia, and acid-peptic disorders associated with nausea or bloating.
Marketed by: Wonne International Pvt. Ltd.

Key Points of Pantoprazole EC 40 Mg & Domperidone (SR) 30 Mg Capsules IP – Zentro DSR Capsules

• Dual Mechanism Action: Pantoprazole reduces gastric acid secretion, while Domperidone enhances gastric emptying and controls nausea.
• Sustained Symptom Control: Enteric coating ensures acid protection of Pantoprazole, and SR technology provides prolonged prokinetic support.
• Effective in Reflux & Dyspepsia: Relieves heartburn, regurgitation, epigastric discomfort, fullness, and nausea.
• Improved Patient Compliance: Once-daily convenient dosing with combined therapeutic benefits.

• General Physician
• Gastroenterologist
• ENT Specialists (for LPR-related symptoms)
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.